Literature DB >> 2263226

Phosphorylcholine antibodies in pulmonary infection.

S Nishinarita1, S Sawada, T Horie.   

Abstract

Phosphorylcholine (PC) antibodies in serum from patients with pulmonary infection, and from normal individuals, were studied. Anti-PC antibodies were detectable in the serum from normal individuals at mean concentrations of 320 micrograms/ml for the IgG class and 110 micrograms/ml for the IgM class. Concentrations of anti-PC antibodies which were higher than normal for both the IgG and IgM classes were observed in the serum in pulmonary infection (1,440 micrograms/ml and 210 micrograms/ml, respectively). Despite the significant difference in the concentration of anti-PC antibodies, the PC-specific B cell precursor frequency in the peripheral blood lymphocytes showed no difference between normal individuals and the patients with pulmonary infection, or between the acute phase and the chronic phase in a single patient with chronic pulmonary infection. Serologically, the purified IgG anti-PC antibody did not share the cross-reactive idiotype of TEPC 15, which is the most common idiotype of the murine anti-PC antibodies. However, the purified IgM anti-PC antibody expressed a very weak cross-reactive idiotype of TEPC 15. It appears from these studies that human anti-PC antibodies may play an important biological role in pulmonary infection by microorganisms which possess a PC determinant.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2263226     DOI: 10.1007/bf00195251

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  27 in total

1.  Heterogeneity of the human phosphocholine-specific B cell repertoire.

Authors:  L D Stein; N H Sigal
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

2.  Studies on antibody repertoire: ontogenic development of mitogen-reactive B cells producing phosphorylcholine-specific and/or T15-associated 10/13 idiotope-positive antibodies.

Authors:  M Lévy
Journal:  Eur J Immunol       Date:  1984-12       Impact factor: 5.532

3.  Subpopulations of antibodies to phosphocholine in human serum.

Authors:  M Brown; G Schiffman; M B Rittenberg
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

4.  Pneumococcal vaccine: development and prospects.

Authors:  R Austrian
Journal:  Am J Med       Date:  1979-10       Impact factor: 4.965

5.  Clonal nature of the immune response to phosphorylcholine. III. Species-specific binding characteristics of rodent anti-phosphorylcholine antibodies.

Authors:  J L Claflin; J M Davie
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

6.  A phosphorylcholine idiotype related to TEPC 15 in mice infected with Ascaris suum.

Authors:  A R Brown; C A Crandall
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

7.  Phosphorylcholine determinants in six pneumococcal capsular polysaccharides detected by monoclonal antibody.

Authors:  U B Sørensen; R Agger; J Bennedsen; J Henrichsen
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

8.  T15 D region germ line amino acid sequences distinguished by monoclonal anti-idiotope antibody.

Authors:  S Nishinarita; J L Claflin; R Lieberman
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

9.  Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine.

Authors:  R Lieberman; M Potter; E B Mushinski; W Humphrey; S Rudikoff
Journal:  J Exp Med       Date:  1974-04-01       Impact factor: 14.307

10.  Anti-phosphocholine hybridoma antibodies. I. Direct evidence for three distinct families of antibodies in the murine response.

Authors:  J L Claflin; S Hudak; A Maddalena
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  7 in total

1.  Opsonization of Actinobacillus actinomycetemcomitans by immunoglobulin G antibody reactive with phosphorylcholine.

Authors:  Donald Purkall; John G Tew; Harvey A Schenkein
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse.

Authors:  Q S Mi; L Zhou; D H Schulze; R T Fischer; A Lustig; L J Rezanka; D M Donovan; D L Longo; J J Kenny
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 3.  Natural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune disease.

Authors:  Caroline Grönwall; Gregg J Silverman
Journal:  J Clin Immunol       Date:  2014-04-02       Impact factor: 8.317

4.  IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL.

Authors:  Roland Fiskesund; Jun Su; Ivana Bulatovic; Max Vikström; Ulf de Faire; Johan Frostegård
Journal:  Results Immunol       Date:  2012-01-08

5.  Antibodies against native and oxidized cardiolipin and phosphatidylserine and phosphorylcholine in atherosclerosis development.

Authors:  Anna G Frostegård; Jun Su; Xiang Hua; Max Vikström; Ulf de Faire; Johan Frostegård
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

6.  Phosphocholine-Modified Lipooligosaccharides of Haemophilus influenzae Inhibit ATP-Induced IL-1β Release by Pulmonary Epithelial Cells.

Authors:  Katrin Richter; Christian Koch; Alexander Perniss; Philipp M Wolf; Elke K H Schweda; Sven Wichmann; Sigrid Wilker; Ilona Magel; Michael Sander; J Michael McIntosh; Winfried Padberg; Veronika Grau
Journal:  Molecules       Date:  2018-08-08       Impact factor: 4.411

7.  Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes.

Authors:  Veronika Grau; Katrin Richter; Arik J Hone; J Michael McIntosh
Journal:  Front Pharmacol       Date:  2019-01-07       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.